Key points are not available for this paper at this time.
An uncomplicated and precise method has come into existence for the simultaneous quantification of emtricitabine, dolutegravir, and tenofovir in solid dosage forms. The chromatographic analysis utilized a Hibar100 column (50×2.1 mm, 2 μm) with a mobile phase of 0.1% OPA and acetonitrile in a 60:40 v/v ratio at a constant flow rate of 1.0 mL/min, maintaining a temperature of 30°C. The perfected wavelength at 260.0 nm revealed retention times of 1.951, 1.180, and 1.584 minutes for dolutegravir, emtricitabine, and tenofovir, respectively.
Babu et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: